Canaccord Drops $6 Million In Cedara's Stocking
Cedara Software has closed a private placement with Canaccord Capital for $6.15 million. The Canadian imaging software firm plans to use the proceeds to finance its operations and the operations of its subsidiaries and to satisfy the payment and interest
Cedara Software has closed a private placement with Canaccord Capital for $6.15 million. The Canadian imaging software firm plans to use the proceeds to finance its operations and the operations of its subsidiaries and to satisfy the payment and interest deferred from Sept. 30 to former owners of Dicomit, acquired in mid-2000. In addition, Cedara will be able to raise another $3.1 million by selling shares in its Surgical Navigation Specialists (SNS) business to the investing lenders. This move will give the investors a maximum 6% interest in SNS.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
